BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
Home » Authors » Kim Coghill

Articles by Kim Coghill

Alkermes Starts Phase III Of Drug For Alcohol Dependence

April 2, 2002
By Kim Coghill

Adolor Moving Analgesic Back To Phase I To Work On Dosing

April 2, 2002
By Kim Coghill

Alkermes Starts Phase III Of Drug For Alcohol Dependence

April 2, 2002
By Kim Coghill

Proposed Bill Would Loosen Research Patent Requirements

April 1, 2002
By Kim Coghill
WASHINGTON - A House Democrat introduced legislation that would allow scientists to conduct research using patented genetic sequence information without obtaining permission from the patent’s owner. (BioWorld Today)
Read More

Proposed Bill Would Loosen Research Patent Requirements

April 1, 2002
By Kim Coghill
WASHINGTON - A House Democrat introduced legislation that would allow scientists to conduct research using patented genetic sequence information without obtaining permission from the patent’s owner. (BioWorld Today)
Read More

Isis’ GeneTrove Signs Pharmacia To Antisense Inhibitor Agreemen

March 28, 2002
By Kim Coghill
Isis Pharmaceuticals Inc. on Wednesday said it signed another major drug company to use its GeneTrove division’s antisense inhibitors for target validation studies. (BioWorld Today)
Read More

Isis’ GeneTrove Signs Pharmacia To Antisense Inhibitor Agreemen

March 28, 2002
By Kim Coghill
Isis Pharmaceuticals Inc. on Wednesday said it signed another major drug company to use its GeneTrove division’s antisense inhibitors for target validation studies. (BioWorld Today)
Read More

Bush Unveils Planned NIH, Surgeon General Nominations

March 27, 2002
By Kim Coghill

ISTA’s Stock Slides On Vitrase Missed Primary Endpoint

March 27, 2002
By Kim Coghill
Wall Street did not look kindly on ISTA Pharmaceuticals’ failure to meet its primary endpoint in two pivotal Phase III studies of Vitrase, a single injection for treating vitreous hemorrhage. (BioWorld Today)
Read More

Bush Unveils Planned NIH, Surgeon General Nominations

March 27, 2002
By Kim Coghill
Previous 1 2 … 126 127 128 129 130 131 132 133 134 … 142 143 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 31, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 31, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing